Erratum to “To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound” [European Journal of Cancer, 42 (2006) 2472–2479]
Article Outline
The Publisher regrets the incorrect classification of the above mentioned article as a review paper. This paper is part of the Clinical Oncology Section of the journal.
PII: S0959-8049(07)00230-4
doi:10.1016/j.ejca.2006.04.034
© 2007 Elsevier Ltd. All rights reserved.
Refers to article:
- To predict progression-free survival and overall survival in metastatic renal cancer treated with sorafenib: Pilot study using dynamic contrast-enhanced Doppler ultrasound
